Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions
JACC: Cardiovascular Interventions · 2024-02 · 17 (4) · 491-501
DOI: 10.1016/j.jcin.2023.12.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2024-02. Verfasst von Kei Yamamoto und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York, USA; Clinical Trials Center, Cardiovascular R…. Hauptthemen laut MEDLINE: Coronary Occlusion, Percutaneous Coronary Intervention, Myocardial Infarction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Intravascular ultrasound (IVUS) studies show that one-quarter of left anterior descending (LAD) arteries have a myocardial bridge. An MB may be associated with stent failure when the stent extends into the MB. OBJECTIVES: The aim of this study was to investigate: 1) the association between an MB and chronic total occlusion (CTO) in any LAD lesions; and 2) the association between an MB and subsequent clinical outcomes after percutaneous coronary intervention in LAD CTOs. METHODS: A total of 3,342 LAD lesions with IVUS-guided percutaneous coronary intervention (280 CTO and 3,062 non-CTO lesions) were included. The primary outcome was target lesion failure (cardiac death, target vessel myocardial infarction, definite stent thrombosis, and ischemic-driven target lesion revascularization). RESULTS: An MB by IVUS was significantly more prevalent in LAD CTOs than LAD non-CTOs (40.4% [113/280] vs 25.8% [789/3,062]; P < 0.0001). The discrepancy in CTO length between angiography and IVUS was greater in 113 LAD CTOs with an MB than 167 LAD CTOs without an MB (6.0 [Q1, Q3: 0.1, 12.2] mm vs 0.2 [Q1, Q3: -1.4, 8.4] mm; P < 0.0001). Overall, 48.7% (55/113) of LAD CTOs had a stent that extended into an MB after which target lesion failure was significantly higher compared to a stent that did not extend into an MB (26.3% vs 0%; P = 0.0004) or compared to an LAD CTO without an MB (26.3% vs 9.6%; P = 0.02). CONCLUSIONS: An MB was more common in LAD CTO than non-CTO LAD lesions. If present, approximately one-half of LAD CTOs had a stent extending into an MB that, in turn, was associated with worse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York, USA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
- Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
- Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
- Division of Cardiology, Showa University Northern Yokohama Hospital, Yokohama, Japan.
- Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
- Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; St. Francis Hospital, Roslyn, New York, New York, USA.
Zitieren
APA
Yamamoto, K., Sugizaki, Y., Karmpaliotis, D., Sato, T., Matsumura, M., Narui, S., Yamamoto, M. H., Fall, K. N., James, E. I., Glinski, J. B., Rabban, M. L., Prasad, M., Ng, V. G., Sethi, S. S., Nazif, T. M., Parikh, S. A., Vahl, T. P., Ali, Z. A., Rabbani, L. E., …, & Maehara, A. (2024). Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions. JACC: Cardiovascular Interventions, 17(4), 491-501. https://doi.org/10.1016/j.jcin.2023.12.017
Vancouver
Yamamoto K, Sugizaki Y, Karmpaliotis D, Sato T, Matsumura M, Narui S, et al. Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions. JACC: Cardiovascular Interventions. 2024;17(4):491-501. doi:10.1016/j.jcin.2023.12.017
BibTeX
@article{Yamamoto2024,
author = {Yamamoto, Kei and Sugizaki, Yoichiro and Karmpaliotis, Dimitri and Sato, Takao and Matsumura, Mitsuaki and Narui, Shuro and Yamamoto, Myong Hwa and Fall, Khady N and James, Elizabeth I and Glinski, John B and Rabban, Maya L and Prasad, Megha and Ng, Vivian G and Sethi, Sanjum S and Nazif, Tamim M and Parikh, Sahil A and Vahl, Torsten P and Ali, Ziad A and Rabbani, LeRoy E and Collins, Michael B and Leon, Martin B and McEntegart, Margaret and Moses, Jeffrey W and Kirtane, Ajay J and Ochiai, Masahiko and Mintz, Gary S and Maehara, Akiko},
title = {Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {4},
pages = {491--501},
doi = {10.1016/j.jcin.2023.12.017}
}
EUVIMED